Heart Failure
Conference Coverage
Exercise training cuts heart failure mortality
Key clinical point: A meta-analysis of 20 randomized controlled studies confirmed that an exercise training intervention in heart failure patients...
Conference Coverage
Flu vaccination cut hospitalizations in heart failure patients
Key clinical point: When heart failure patients received an influenza vaccination, their rate of hospitalization for cardiovascular disease and...
News
Implanted phrenic-nerve stimulator improves central sleep apnea
Key clinical point: An implanted device that cuts patients’ apnea-hypopnea index was safe and effective, based on results from a pivotal trial....
Conference Coverage
Nitroxl prodrug shows promise in acute heart failure
Intravenous infusion of a nitroxyl prodrug for 6 hours showed safety and several promising hemodynamic effects in a pilot, controlled study with...
News
Guidelines add two new heart failure treatments
Conference Coverage
Rhythm control may be best for atrial fib in HFpEF
Key clinical point: Atrial fibrillation in patients with heart failure with preserved ejection fraction is associated with exercise intolerance...
Conference Coverage
Prompt antidepressant treatment swiftly chops cardiovascular risk
CHICAGO – The cardiovascular event rate was no different in “no longer depressed” group than in “never depressed.”
Conference Coverage
Exercise is protective but underutilized in atrial fib patients
Nearly 40% of atrial fibrillation patients report having no physical activity.
Conference Coverage
Drilling down on end-of-life health care costs in heart failure
Key clinical point: Addressing lack of adherence to guideline-directed medical therapy could curb end-of-life health care costs in heart failure....
Conference Coverage
Acute heart failure mortality climbs with severity of peripheral edema
Leg swelling warrants greater attention in patients hospitalized for acute heart failure.
Conference Coverage
Valve hemodynamic deterioration 2.5% at 1 year
Key clinical point: The incidence of valve hemodynamic deterioration after transaortic valve replacement is 2.5% from day 30 through 12 months...